Congress Asset Management Co. MA Makes New $2.56 Million Investment in Simulations Plus, Inc. (NASDAQ:SLP)

Share on StockTwits

Congress Asset Management Co. MA acquired a new position in shares of Simulations Plus, Inc. (NASDAQ:SLP) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 73,722 shares of the technology company’s stock, valued at approximately $2,558,000. Congress Asset Management Co. MA owned 0.42% of Simulations Plus at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in SLP. Wells Fargo & Company MN lifted its holdings in shares of Simulations Plus by 10.0% during the second quarter. Wells Fargo & Company MN now owns 45,738 shares of the technology company’s stock worth $1,307,000 after buying an additional 4,143 shares in the last quarter. Meadow Creek Investment Management LLC raised its stake in Simulations Plus by 419.4% in the second quarter. Meadow Creek Investment Management LLC now owns 5,474 shares of the technology company’s stock valued at $156,000 after purchasing an additional 4,420 shares in the last quarter. Bahl & Gaynor Inc. raised its stake in Simulations Plus by 10.7% in the second quarter. Bahl & Gaynor Inc. now owns 124,012 shares of the technology company’s stock valued at $3,542,000 after purchasing an additional 11,968 shares in the last quarter. Campbell & CO Investment Adviser LLC raised its stake in Simulations Plus by 13.0% in the second quarter. Campbell & CO Investment Adviser LLC now owns 23,221 shares of the technology company’s stock valued at $663,000 after purchasing an additional 2,669 shares in the last quarter. Finally, Northern Trust Corp raised its stake in Simulations Plus by 1.6% in the second quarter. Northern Trust Corp now owns 168,006 shares of the technology company’s stock valued at $4,798,000 after purchasing an additional 2,603 shares in the last quarter. 41.35% of the stock is owned by hedge funds and other institutional investors.

Several brokerages have commented on SLP. BidaskClub downgraded Simulations Plus from a “buy” rating to a “hold” rating in a research note on Wednesday. ValuEngine downgraded Simulations Plus from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Zacks Investment Research raised Simulations Plus from a “hold” rating to a “buy” rating and set a $38.00 target price for the company in a research note on Wednesday, October 30th. Finally, Liberum Capital reissued a “buy” rating on shares of Simulations Plus in a research note on Tuesday, October 22nd. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of $38.00.

In other news, Director Walter S. Woltosz sold 24,000 shares of the company’s stock in a transaction that occurred on Sunday, October 27th. The stock was sold at an average price of $33.45, for a total transaction of $802,800.00. Following the transaction, the director now directly owns 5,063,918 shares of the company’s stock, valued at $169,388,057.10. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders have sold 72,000 shares of company stock worth $2,532,720 over the last ninety days. 31.57% of the stock is owned by insiders.

Shares of Simulations Plus stock traded up $0.27 on Friday, reaching $33.25. 100,300 shares of the company’s stock were exchanged, compared to its average volume of 92,136. The company has a market capitalization of $592.56 million, a P/E ratio of 66.50 and a beta of -0.34. Simulations Plus, Inc. has a 52 week low of $17.18 and a 52 week high of $41.95. The firm’s 50-day moving average is $34.58 and its two-hundred day moving average is $31.43.

The company also recently announced a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Friday, October 25th were given a dividend of $0.06 per share. This represents a $0.24 dividend on an annualized basis and a dividend yield of 0.72%. The ex-dividend date of this dividend was Thursday, October 24th. Simulations Plus’s payout ratio is 48.00%.

Simulations Plus Profile

Simulations Plus, Inc develops drug discovery and development software for mechanistic modeling and simulation, and machine-learning-based prediction of properties of molecules from their structure worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), pharmacodynamics, and drug-drug interactions of compounds administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments that measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments.

See Also: P/E Growth (PEG)

Want to see what other hedge funds are holding SLP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Simulations Plus, Inc. (NASDAQ:SLP).

Institutional Ownership by Quarter for Simulations Plus (NASDAQ:SLP)

Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Continental Resources, Inc.  Forecasted to Earn FY2019 Earnings of $2.11 Per Share
Continental Resources, Inc. Forecasted to Earn FY2019 Earnings of $2.11 Per Share
Peoples Bancorp Inc.  Forecasted to Post Q4 2019 Earnings of $0.66 Per Share
Peoples Bancorp Inc. Forecasted to Post Q4 2019 Earnings of $0.66 Per Share
Brokers Set Expectations for IAA’s FY2019 Earnings
Brokers Set Expectations for IAA’s FY2019 Earnings
FY2019 EPS Estimates for Osmotica Pharmaceuticals PLC Raised by Analyst
FY2019 EPS Estimates for Osmotica Pharmaceuticals PLC Raised by Analyst
Mackie Analysts Give Dolly Varden Silver  a C$1.00 Price Target
Mackie Analysts Give Dolly Varden Silver a C$1.00 Price Target
Deutsche Bank Analysts Give Vivendi  a €37.00 Price Target
Deutsche Bank Analysts Give Vivendi a €37.00 Price Target


 
© 2006-2019 Zolmax.